| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/27/2015 | US8940695 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
| 01/27/2015 | US8940693 Protein for the immunocastration for mammals |
| 01/27/2015 | US8940687 Antimicrobial angiogenin complexes (ANGex) and uses thereof |
| 01/27/2015 | US8940534 Immortalized avian cell lines for virus production |
| 01/27/2015 | US8940517 Methods for isolating and quantifying antigen from vaccines |
| 01/27/2015 | US8940489 Monoclonal antibody against D-dimer and diagnosis agent for detecting D-dimer, crosslinked fibrin and its derivatives containing D-dimer by using the antibody |
| 01/27/2015 | US8940309 One dose vaccination against mycoplasma infections of pigs |
| 01/27/2015 | US8940308 Methods for treating depression |
| 01/27/2015 | US8940307 Lectin compositions and methods for modulating an immune response to an antigen |
| 01/27/2015 | US8940306 Method for enhancing immune response with peptide |
| 01/27/2015 | US8940305 Formulation of human antibodies for treating TNF-α associated disorders |
| 01/27/2015 | US8940303 CD127 binding proteins |
| 01/27/2015 | US8940302 Predicting response to a HER inhibitor |
| 01/27/2015 | US8940301 Breast tumor treatment with anti-CXCR1 compositions |
| 01/27/2015 | US8940300 Humanized antibodies targeting the EC1 domain of Cadherin-11 and related compositions and methods |
| 01/27/2015 | US8940299 Method of treating cancer |
| 01/27/2015 | US8940298 High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection |
| 01/27/2015 | US8940276 Human anti-alpha-synuclein antibodies |
| 01/27/2015 | US8940272 Human anti-tau antibodies |
| 01/27/2015 | CA2813040C Secreted campylobacter flagella coregulated proteins as immunogens |
| 01/27/2015 | CA2741419C Anti-fmd vaccine composition and preparation and use thereof |
| 01/27/2015 | CA2733866C Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 01/27/2015 | CA2679548C Methods and compositions for treating tumor diseases |
| 01/27/2015 | CA2632094C Carbonic anhydrase ix (g250) antibodies and methods of use thereof |
| 01/27/2015 | CA2577165C Oral killed vaccines and method for providing same |
| 01/27/2015 | CA2575901C A method of treating cancer comprising a vegf-b antagonist |
| 01/27/2015 | CA2563080C Monoclonal antibodies to hepatocyte growth factor |
| 01/27/2015 | CA2561719C Vaccine comprising an attenuated pestivirus |
| 01/27/2015 | CA2515699C Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 01/27/2015 | CA2501653C Human anti-ifn-.gamma. neutralizing antibodies as selective ifn-.gamma. pathway inhibitors |
| 01/27/2015 | CA2483285C Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same |
| 01/27/2015 | CA2477409C Process for the preparation of hypoallergenic major birch pollen allergen rbet v 1 |
| 01/27/2015 | CA2470104C Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation |
| 01/22/2015 | WO2015010125A1 Antibodies against chikungunya virus and uses thereof |
| 01/22/2015 | WO2015010118A2 Transthyretin amyloid-selective and polyreactive catabodies |
| 01/22/2015 | WO2015010073A1 Attenuated influenza vaccines and uses thereof |
| 01/22/2015 | WO2015010070A1 Cpg-oligodeoxynucleotide, immunogenic composition comprising the same, and methods for preparing the composition and stimulating immune response thereby |
| 01/22/2015 | WO2015010002A1 Methods for preparing inactivated rotavirus |
| 01/22/2015 | WO2015009996A1 Compositions and methods for treating eosinophilic esophagitis |
| 01/22/2015 | WO2015009961A1 Compositions and methods related to structures that cross the blood brain barrier |
| 01/22/2015 | WO2015009952A1 Non-toxic hsv vectors for efficient gene delivery applications and complementing cells for their production |
| 01/22/2015 | WO2015009856A2 Methods of treating cancer using pd-1 axis binding antagonists and tigit inhibitors |
| 01/22/2015 | WO2015009591A2 Treatment for melanoma |
| 01/22/2015 | WO2015009094A1 Composition containing ppar-ν neddylation inhibitor for inhibiting adipocyte differentiation and use thereof |
| 01/22/2015 | WO2015007903A1 Targeted modified tnf family members |
| 01/22/2015 | WO2015007887A1 Combination of a ligand of hvem and an immunotoxin for use in therapy |
| 01/22/2015 | WO2015007880A1 Antibodies recognizing the n-terminal part of tissue factor pathway inhibitor capable of eliciting pro-coagulant activity |
| 01/22/2015 | WO2015007398A1 Method for preparing solid lipid nanoparticles containing antibodies in ion pair form using the fatty acid coacervation technique |
| 01/22/2015 | WO2015007337A1 Method for the vaccination against hiv |
| 01/22/2015 | WO2015006833A1 A method for treating type 1 diabetes |
| 01/22/2015 | US20150024489 Device for enhancing immunostimulatory capabilities of T-cells |
| 01/22/2015 | US20150024484 Antibody Inhibitors of GDF-8 and Uses Thereof |
| 01/22/2015 | US20150024038 Immunogenic Compositions and Methods |
| 01/22/2015 | US20150024037 Xenoantigen-Displaying Anti-Cancer Vaccines and Method of Making |
| 01/22/2015 | US20150024026 Scaffolds For Cell Transplantation |
| 01/22/2015 | US20150024007 Long term disease modification using immunostimulatory oligonucleotides |
| 01/22/2015 | US20150024006 Allogeneic cellular immunotherapy for opportunistic infection |
| 01/22/2015 | US20150024005 Augmentation of titer for vaccination in animals |
| 01/22/2015 | US20150024004 Flavivirus vaccines |
| 01/22/2015 | US20150024003 Method for the production of recombinant virus, dna constructs, recombinant virus and vaccine compositions |
| 01/22/2015 | US20150024002 Alphavirus vectors for respiratory pathogen vaccines |
| 01/22/2015 | US20150024001 Molecular mimic mucosal aids vaccine |
| 01/22/2015 | US20150024000 Multivalent vaccine protection from staphylococcus aureus infection |
| 01/22/2015 | US20150023999 Novel Targets of Acinetobacter Baumannii |
| 01/22/2015 | US20150023998 Stable Anthrax Vaccine Formulations |
| 01/22/2015 | US20150023997 Compositions, methods and therapies for administering antigen peptide |
| 01/22/2015 | US20150023996 Polynucleotides for treating oncogenic viral polypeptide positive tumors |
| 01/22/2015 | US20150023995 Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity |
| 01/22/2015 | US20150023993 Combination therapy using active immunotherapy |
| 01/22/2015 | US20150023987 Immunogenic compositions and reagents for preparing |
| 01/22/2015 | US20150023985 Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition |
| 01/22/2015 | US20150023982 Methods of administering anti-tnfalpha antibodies |
| 01/22/2015 | US20150023980 Combination pharmaceutical composition and methods of treating and preventing the infectious diseases |
| 01/22/2015 | US20150023976 Antibody polypeptides that antagonize cd40l |
| 01/22/2015 | US20150023975 PAR-1 Activation by Metalloproteinase-1 (MMP-1) |
| 01/22/2015 | US20150023971 Modulation of Activity of Proneurotrophins |
| 01/22/2015 | US20150023968 Compositions and methods for diagnosing and treating hyperthyroidism in companion animals |
| 01/22/2015 | US20150023967 Binding molecules for bcma and cd3 |
| 01/22/2015 | US20150023964 FcgammaRIIB-Specific Antibodies and Methods of Use Thereof |
| 01/22/2015 | US20150023962 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 01/22/2015 | US20150023961 Methods of modulating immunological responses by administering truncated baff receptors |
| 01/22/2015 | US20150023960 Compositions and Methods of Use for Treating Metabolic Disorders |
| 01/22/2015 | US20150023954 Potentiating antibody-induced complement-mediated cytotoxicity via pi3k inhibition |
| 01/22/2015 | US20150023920 Novel compositions and methods for preventing or treating cancer metastasis |
| 01/22/2015 | US20150023915 Treatment for melanoma |
| 01/22/2015 | US20150023910 Granulysin in immunotherapy |
| 01/22/2015 | US20150023909 Lymph node-targeting nanoparticles |
| 01/22/2015 | US20150023871 Compositions and methods for the diagnosis and treatment of tumor |
| 01/21/2015 | EP2826791A2 Humanized anti-C5aR antibodies |
| 01/21/2015 | EP2826790A1 Gremlin-1 antibody |
| 01/21/2015 | EP2826789A1 Antibody constant region variant |
| 01/21/2015 | EP2826486A1 Agent for the treatment of hepatitis c virus |
| 01/21/2015 | EP2825560A1 Bi-specific adapters |
| 01/21/2015 | EP2825201A1 The filamentous bacteriophage as an angiogenesis modulator |
| 01/21/2015 | EP2825200A1 Human anti-cd27 antibodies, methods and uses |
| 01/21/2015 | EP2825199A1 Human autotaxin antibodies and methods of use |
| 01/21/2015 | EP2825198A1 Cancer therapeutics |
| 01/21/2015 | EP2825197A1 Novel binding molecules with antitumoral activity |
| 01/21/2015 | EP2825196A1 Adjuvant and vaccine compositions |
| 01/21/2015 | EP2825195A1 Suppressor cell function inhibition following listeria vaccine treatment |